Please login to the form below

Not currently logged in
Email:
Password:

tezacaftor

This page shows the latest tezacaftor news and features for those working in and with pharma, biotech and healthcare.

Vertex rises on data for cystic fibrosis triple therapy

Vertex rises on data for cystic fibrosis triple therapy

The interim results come from two studies of its two-drug therapy Symdeko (ivacaftor/tezacaftor) – which has just been approved as Symkevi in Europe – with experimental candidate VX-659, and reveal

Latest news

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics